Published in
Springer (part of Springer Nature), Cancer Chemotherapy and Pharmacology, 1(72), p. 117-125
DOI: 10.1007/s00280-013-2175-0
Links
Tools
MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination
Journal article published in 2013 by
Lucio Tentori,
Alessia Muzi,
Annalisa Susanna Dorio,
Susanna Dolci,
Federica Campolo,
Patrizia Vernole,
Pedro Miguel Lacal,
Françoise Praz,
Grazia Graziani 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 